ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,775,013, issued on Oct. 27, was assigned to Seattle Children's Hospital (Seattle) and Battelle Memorial Institute (Richland, Wash.).

"Immunomodulatory clinical biomarker profiles and uses thereof" was invented by Heather Gustafson (Seattle), Rebecca Gardner (Seattle), Bobbie-Jo M. Webb-Robertson (Seattle) and Katelyn Burleigh (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to biomarker profiles and their use to predict a subject's response to an immunomodulatory treatment. Biomarkers in these profiles include cytokines and other proteins associated with the interleukin 1 family and the type 1 interferon family. Par...